MedCity News |
Keryx’s chronic kidney disease drug shows reduction in serum phosphorus
MedCity News (Reuters) – Keryx Biopharmaceuticals Inc said its kidney drug met the main goals of a mid-stage study in patients with chronic kidney disease who were not on dialysis. Shares of the company rose about 16 percent to $12.84 in premarket trading. The drug … Keryx says kidney drug effective; shares hit seven-year highReuters India Keryx Says Kidney Disease Drug Zerenex WorkedDrug Discovery & Development Why Keryx Shares SkyrocketedMotley Fool Wall Street Journal all 31 news articles » |
Insomnia concerns go unaddressed in heart failure patients – News-Medical.net
|
Insomnia concerns go unaddressed in heart failure patients
News-Medical.net The impact of insomnia on health and function is a major concern for patients with heart failure (HF), qualitative and quantitative research shows. “Our findings underscore the critical importance of evaluating sleep, including insomnia,” says the … |
Stage and grade dominate RCC outcomes – News-Medical.net
Stage and grade dominate RCC outcomesNews-Medical.netTumor grade and American Joint Committee on Cancer stage have emerged as the most important predictors of mortality in a competing risks analysis of patients undergoing nephrectomy for renal cell car…
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime … – PharmiWeb.com (press release)
|
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime …
PharmiWeb.com (press release) Under the agreement ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately adding to ADC Therapeutics’ portfolio of proprietary ADC programs. |
Dancers Raise Awareness For Organ Donation – WCHS-TV8
WCHS-TV8Dancers Raise Awareness For Organ DonationWCHS-TV8An international group of dancers stopped in Institute to help bring awareness to the importance of organ donation. Step Afrika performed at West Virginia State University Monday evening. The gr…
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime … – 4-traders (press release)
|
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime …
4-traders (press release) Under the agreement, ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately, adding to ADC Therapeutics’ portfolio of proprietary ADC programs. |
Newly discovered monoclonal antibodies could control HIV – Vaccine News Daily
Vaccine News Daily |
Newly discovered monoclonal antibodies could control HIV
Vaccine News Daily A recently discovered group of monoclonal antibodies could serve as a new tool to control HIV, according to a study published on Wednesday in Nature. A team of scientists from the La Jolla, Calif.-based The Scripps Research Institute and other … AIDS antibodies fight infection in monkeysPrivate MD Theraclone Sciences’ Monoclonal Antibody Candidate PGT121 Suppresses HIV …EON: Enhanced Online News (press release) New experiment found suppressant for HIV-like virusSoutheast Missourian International Business Times AU all 6 news articles » |
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD … – Virtual-Strategy Magazine (press release)
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD …Virtual-Strategy Magazine (press release)This initial exchange between Bioquark Inc., a novel development stage company focused on biological approaches to human regenera…
MK-3475 – Scientists develop new drug that could potentially cure lung cancer – India.Com Health
MK-3475 – Scientists develop new drug that could potentially cure lung cancerIndia.Com HealthScientists have found a new experimental drug called MK-3475 that could potentially be used to treat patients with lung cancer. The drug has already shown pote…
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD … – PR Web (press release)
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD …PR Web (press release)This initial exchange between Bioquark Inc., a novel development stage company focused on biological approaches to human regeneration and repair, an…